AcaMedics (@acamedics) 's Twitter Profile
AcaMedics

@acamedics

AcaMedics is a international scheme for doctors and medical students. It is all about getting more involved in cutting edge research and audit!

ID: 930120157

linkhttp://acamedics.org/ calendar_today06-11-2012 16:57:49

124 Tweet

115 Takipçi

169 Takip Edilen

nature (@nature) 's Twitter Profile Photo

Latest #coronavirus research: 👉Mutations in SARS-CoV-2 might help the virus to thwart antibodies. 👉Power of China’s virus-control campaign is seen in pattern of symptoms. 👉Cats and dogs just as likely to be infected with SARS-CoV-2 as people are. go.nature.com/30aAChy

NEJM (@nejm) 's Twitter Profile Photo

In this letter, the investigators report that saliva specimens and nasopharyngeal swab specimens had similar sensitivity in the detection of SARS-CoV-2 RNA in both symptomatic and asymptomatic persons.

NEJM (@nejm) 's Twitter Profile Photo

A 35-year-old man presented with a 6-month history of increased swelling in his right leg. Physical exam revealed firmness in the right lower leg without tenderness to palpation. Magnetic resonance imaging of the area revealed multiple cystic lesions. What is the diagnosis?

University of Oxford (@uniofoxford) 's Twitter Profile Photo

NEW: Oxford researchers find malaria vaccine is highly effective: • Vaccine efficacy of 77% in African children • Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated More info ⬇️ bit.ly/3dP47fH

Neurogastro Dietitian (@leemartinrd) 's Twitter Profile Photo

Finding⌛️ in a clinical role to do research is a lot harder than actually doing the research! But in 2022 I somehow manged 5 publications (see 🧵) So👏 to me, my colleagues in the GI Physiology Unit UCLH, MSc students UCL & Michele Chan from AcaMedics Thank you for your help

Neurogastro Dietitian (@leemartinrd) 's Twitter Profile Photo

UCLH UCL AcaMedics BAPEN UK Simon Gabe Anton Emmanuel #FODMAP Restriction as effective in #IBS-C as IBS-D (~60%) when delivered in dietetic group education UCLH & does not⬆️#constipation in IBS-C❗️ 📢44% IBS-C 💱 to IBS-U & were more likely to achieve satisfactory😮‍💨 See page 408 (Abstract P1034) onlinelibrary.wiley.com/doi/epdf/10.10… UEGJ

<a href="/uclh/">UCLH</a> <a href="/ucl/">UCL</a> <a href="/AcaMedics/">AcaMedics</a> <a href="/BAPENUK/">BAPEN UK</a> <a href="/simongabe/">Simon Gabe</a> <a href="/AntonEmmanuel2/">Anton Emmanuel</a> #FODMAP Restriction as effective in #IBS-C as IBS-D (~60%) when delivered in dietetic group education <a href="/uclh/">UCLH</a> &amp; does not⬆️#constipation in IBS-C❗️ 
📢44% IBS-C 💱 to IBS-U &amp; were more likely to achieve satisfactory😮‍💨
See page 408 (Abstract P1034) onlinelibrary.wiley.com/doi/epdf/10.10… <a href="/UEGJournal/">UEGJ</a>
Neurogastro Dietitian (@leemartinrd) 's Twitter Profile Photo

UCLH UCL AcaMedics BAPEN UK Simon Gabe Anton Emmanuel UEGJ June @JHNDEditor our GROUP EDUCATION #FODMAPs study onlinelibrary.wiley.com/doi/full/10.11… Provides📈evidence for efficacy in this approach in #IBS ➕novel findings: 🥇to suggest no ⬆️risk of ED from #FODMAP Restriction (SCOFF) ➡️Accompanied by editorial Kevin Whelan onlinelibrary.wiley.com/doi/10.1111/jh…

<a href="/uclh/">UCLH</a> <a href="/ucl/">UCL</a> <a href="/AcaMedics/">AcaMedics</a> <a href="/BAPENUK/">BAPEN UK</a> <a href="/simongabe/">Simon Gabe</a> <a href="/AntonEmmanuel2/">Anton Emmanuel</a> <a href="/UEGJournal/">UEGJ</a> June @JHNDEditor our GROUP EDUCATION #FODMAPs study onlinelibrary.wiley.com/doi/full/10.11… Provides📈evidence for efficacy in this approach in #IBS ➕novel findings: 🥇to suggest no ⬆️risk of ED from #FODMAP Restriction (SCOFF) 
➡️Accompanied by editorial <a href="/ProfWhelan/">Kevin Whelan</a>  onlinelibrary.wiley.com/doi/10.1111/jh…
Harvard T.H. Chan School of Public Health (@harvardchansph) 's Twitter Profile Photo

The HBNU Fogarty Global Health Fellowship is recruiting early-career researchers from the US and internationally! This 1-year fellowship supports research at 22 LMIC sites. Visit the HBNU website to learn more and register for the info session: hsph.me/HBNU

NEJM Journal Watch (@jwatch) 's Twitter Profile Photo

Tirzepatide significantly decreased the risk for a composite endpoint of worsening heart failure or cardiovascular death in patients with heart failure with preserved ejection fraction and obesity. jwat.ch/4g3b4GX #CardioTwitter Vlad Zaha NEJM

Tirzepatide significantly decreased the risk for a composite endpoint of worsening heart failure or cardiovascular death in patients with heart failure with preserved ejection fraction and obesity. jwat.ch/4g3b4GX

#CardioTwitter <a href="/vgzmd/">Vlad Zaha</a> <a href="/NEJM/">NEJM</a>
NEJM (@nejm) 's Twitter Profile Photo

The combination of nivolumab and ipilimumab in patients with metastatic colorectal cancer led to 24-month progression-free survival of 72%, as compared with 14% with chemotherapy. Read the full CheckMate 8HW trial results: nej.md/4eGp1tj

The combination of nivolumab and ipilimumab in patients with metastatic colorectal cancer led to 24-month progression-free survival of 72%, as compared with 14% with chemotherapy. Read the full CheckMate 8HW trial results: nej.md/4eGp1tj
NEJM Journal Watch (@jwatch) 's Twitter Profile Photo

Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation A large, randomized trial in China shows improved efficacy with extensive ablation. jwat.ch/4fjKx7B #CardioTwitter

Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation

A large, randomized trial in China shows improved efficacy with extensive ablation. jwat.ch/4fjKx7B

#CardioTwitter
NEJM Evidence (@nejmevidence) 's Twitter Profile Photo

How do we make sense of two “negative” trials in NEJM and a “positive” meta-analysis of the two trials in NEJM Evidence? Emil Hodzic-Santor and Michael Fralick share some insights in this editorial: eviden.cc/3OYutgJ

How do we make sense of two “negative” trials in <a href="/NEJM/">NEJM</a> and a “positive” meta-analysis of the two trials in NEJM Evidence? <a href="/emil_hs/">Emil Hodzic-Santor</a> and <a href="/FralickMike/">Michael Fralick</a> share some insights in this editorial: eviden.cc/3OYutgJ